Activation of NF-κB is a feature of many chronic inflammatory conditions including asthma [21], chronic obstructive pulmonary disease [22], and rheumatoid arthritis [23] as well as in (non-lymphoid) malignancies [24]. This evidence concerns the gene NFKB1 and chronic obstructive pulmonary disease.